I 2.95    Updated: 04-28-2017 $I Last Trade:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
29
I 2.95    Updated: 04-28-2017 $I
Last Trade: 4/28/2017
Last 2.95   
Open 3.50
Previous Close 2.95
Day High / Low 3.50 / 2.90
Year High / Low 5.87 / 2.12
Volume 1,407,192
Projected Volume 1407192 (298%)
# of Trades / Projected 3,646 / 3,646
Dividend / Yield - / 0.00%
Abnormal Activity ABNORMAL DAY DOWN
Abnormal Volume ABNORMAL VOLUME
Gap NONE
Candle BEARISH
Volatility Today HIGH
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 66%
From 80 Day High 50%
From 150 Day High 50%
From 40 Day Low 85%
From 80 Day Low 105%
From 150 Day Low 120%
Pivot Analysis
Price Pivot $ 3.12
Day Resistance 1 $ 3.33
Day Support 1 $ 2.73
Day Resistance 2 $ 3.72
Day Support 2 $ 2.52
Consolidations
Short Term NO
Medium Term NO
Long Term YES
Volume Indicators
20 Day Avg Vol 472,621
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 507,403
Today / 150 Day Avg Vol ABOVE
Abnormal Volume ABNORMAL VOLUME
William Volume Accumulation bearish
Volume Price Trend bearish
Momentum Indicators
10 Day Trend bearish
40 Day Trend bearish
100 Day Trend bullish
Stochastics neutral
RSI neutral
MACD bearish
Moving Average Indictors
15 Day Trend bearish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY DOWN
Volatility Index Today HIGH
Volatility Index Yesterday MEDIUM
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading